These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2238967)

  • 1. [Initial experiences in diagnosis of graft rejection following clinical heart transplantation. Detection of graft-directed activated T-cells].
    Werner M; Otto U; Keitel R; Klötzer B; Schürer KD; Walther J; Vogt S; Ambrosius H
    Zentralbl Chir; 1990; 115(14):905-12. PubMed ID: 2238967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
    Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The coronary sinus as a source of activated T-lymphocytes in patients after orthotopic heart transplantation].
    Holzinger C; Zuckermann A; Schöllhammer A; Kopp C; Imhof M; Laufer G; Griesmacher A; Zwölfer W; Laczkovics A; Wolner E
    Wien Klin Wochenschr; 1992; 104(24):748-52. PubMed ID: 1288018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma delta T cells play no major role in human heart allograft rejection.
    Coelho V; Moliterno R; Higuchi ML; Guilherme L; Cunha-Neto E; Fiorelli AI; Kalil J
    Transplantation; 1995 Nov; 60(9):980-4. PubMed ID: 7491704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy.
    Hosenpud JD; Everett JP; Morris TE; Wagner CR; Shipley GD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S185-7. PubMed ID: 8719483
    [No Abstract]   [Full Text] [Related]  

  • 9. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CD45RA- CD45RO+ "memory" T cells in patients after kidney, heart, and liver transplantation.
    Winkler M; Schwinzer R; Wonigeit K; Ringe B; Pichlmayr R
    Transplant Proc; 1992 Dec; 24(6):2532-4. PubMed ID: 1465856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Noninvasive monitoring of rejection in heart transplant patients. An overview of current status and use at a small transplant center].
    Wasler A; Petutschnigg B; Iberer F; Auer T; Tscheliessnigg KH
    Wien Klin Wochenschr; 1991; 103(4):105-10. PubMed ID: 2042368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change of T-lymphocyte ratio after keratoplasty.
    Kelenhegyi C; Süveges I; Alberth B
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jun; 210(4):269-74. PubMed ID: 386821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses during pig-to-primate xenotransplantation.
    Davila E; Byrne GW; LaBreche PT; McGregor HC; Schwab AK; Davies WR; Rao VP; Oi K; Tazelaar HD; Logan JS; McGregor CG
    Xenotransplantation; 2006 Jan; 13(1):31-40. PubMed ID: 16497210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of donor lymphocytes in human hepatic grafts with immune activation but no clinical rejection.
    Kanehiro H; Steinhoff G; Nashan B; Pichlmayr R; Schlitt HJ
    Transplant Proc; 1993 Apr; 25(2):1764-5. PubMed ID: 7682350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of T-cell subpopulations and expression patterns of lymphocytic activation markers in patients in the early phase following kidney transplantation using laser flow cytometry].
    Kaden J; Falck P; Eichler C; Strobelt V; May G; Volk HD
    Z Urol Nephrol; 1989 Oct; 82(10):531-9. PubMed ID: 2575311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.